Affinity Asset Advisors »

Tectonic Therapeutic shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Tectonic Therapeutic shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Tectonic Therapeutic

Tip: Access up to 7 years of quarterly data

All positions including Tectonic Therapeutic held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tectonic Therapeutic by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-06-30 $961k 58k 16.47

More positions owned by Affinity Asset Advisors

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Xenon Pharmaceuticals (XENE)
Apogee Therapeutics (APGE)
Madrigal Pharmaceuticals (MDGL)
Cerevel Therapeutics Hldng I (CERE)
Arcellx Common Stock (ACLX)
Crinetics Pharmaceuticals In (CRNX)
Nurix Therapeutics (NRIX)
Celldex Therapeutics Com New (CLDX)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Alnylam Pharmaceuticals Note 1.000% 9/1 (Principal)
Beigene Sponsored Adr (BGNE)
Alkermes SHS (ALKS)
Nuvalent Inc-a (NUVL)

View all positions for Affinity Asset Advisors

Top funds holding Tectonic Therapeutic

EcoR1 Capital
5AM Venture Management
BML Capital Management
Farallon Capital Management
Atlas Venture Life Science Advisors
Vanguard Group
Verition Fund Management
Acadian Asset Management
Renaissance Technologies
Aisling Capital Management
Tang Capital Management
Ikarian Capital
Affinity Asset Advisors
BlackRock
Aldebaran Capital

View all funds holding Tectonic Therapeutic